Company Summary

Glaxosmithkline Consumer Healthcare Ireland Ip Limited was set up on Friday the 5th of December 2014. Their current partial address is Waterford, and the company status is Dissolved with the company closing on Wednesday the 10th of March 2021. The company's current directors have been the director of 18 other Irish companies between them; 10 of which are now closed. Glaxosmithkline Consumer Healthcare Ireland Ip Limited has 1 shareholder. This Irish company shares its Eircode with at least 2 other companies.

Company Name:Glaxosmithkline Consumer Healthcare Ireland Ip Limited
Company Status:DISSOLVED
Company Address:Knockbrack,
Dungarvan, Waterford, Ireland
Company Size:Log-In To View
Established:05/12/2014 (7 years in business).

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Glaxosmithkline Consumer Healthcare Ireland Ip Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
E4 LIQUIDATOR PERIODIC STATEMENT OF ACCOUNT16/09/202027/11/2020Join Up
E4 LIQUIDATOR PERIODIC STATEMENT OF ACCOUNT11/09/202027/11/2020Join Up
E3 LIQUIDATORS A/C OF HIS ACTS AND DEALINGS11/09/202027/11/2020Join Up
E5 LIQUIDATORS FINAL STATEMENT OF ACCOUNT16/09/202027/11/2020Join Up
E6 FINAL WINDING UP MEETING - MEMBERS VOL WINDIN16/09/202027/11/2020Join Up
THIS COMPANY HAS 46 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Glaxosmithkline Consumer Healthcare Ireland Ip Limited.

Company Status:Dissolved
Latest Credit Movement:
Date of Last Movement:05/08/2025
Latest Accounts Filed:23/10/2018
Report Based on Accounts:31/12/2017
Next Set of Accounts Due:30/09/2019
Overdue:Yes
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Glaxosmithkline Consumer Healthcare Ireland Ip Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Glaxosmithkline Consumer Healthcare Ireland Ip Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Glaxosmithkline Consumer Healthcare Ireland Ip Limited and Anti-Money Laundering checks (AML checks) on Glaxosmithkline Consumer Healthcare Ireland Ip Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:1

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Glaxosmithkline Consumer Healthcare Ireland Ip Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

Strengthening AML Compliance in Ireland

30/03/2026

The EU's sixth Anti-Money Laundering Directive (AMLD6) represents one of the most significant shifts in Europe's financial crime framework in over a decade - with Irish businesses already feeling its impact.

Read More »

Batch Enrichment for Faster Compliance

12/03/2026

Did you know your existing customer records can be enriched with key KYC, AML and risk intelligence through a single, streamlined batch process?

Read More »

Ireland's Directorship Trends: A 2026 Data Snapshot

09/03/2026

As of today, Ireland has over 757,000 company directors, reflecting the scale and complexity of the country?s corporate environment.

Read More »

Ireland's Business Insights Report

27/02/2026

Insights into Start-Up Resilience, Market Challenges and the Changing Risk Environment...

Read More »